DOSE-RELATED PHARMACOKINETICS AFTER ORAL-ADMINISTRATION OF A NEW FORMULATION OF ERYTHROMYCIN BASE

被引：32

作者：

JOSEFSSON, K

BERGAN, T

MAGNI, L

机构：

[1] UNIV OSLO,INST PHARM,DEPT MICROBIOL,OSLO,NORWAY

[2] ASTRA LAKEMEDEL AB,RES & DEV LABS,S-15185 SODERTALJE,SWEDEN

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 13卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1982.tb01437.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：685 / 691

页数：7

相关论文

共 19 条

[1] INTERSUBJECT AND DOSE-RELATED VARIABILITY AFTER INTRAVENOUS ADMINISTRATION OF ERYTHROMYCIN
AUSTIN, KL
MATHER, LE
PHILPOT, CR
MCDONALD, PJ
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) : 273 - 279
[2] PLASMA AND SALIVA CONCENTRATIONS FOR A NEW FORMULATION OF ERYTHROMYCIN STEARATE
BEREND, N
RUTLAND, J
MARLIN, GE
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 (02) : 118 - 123
[3] PHARMACOKINETICS OF JOSAMYCIN - NEW MACROLIDE ANTIBIOTIC
BERGAN, T
OYDVIN, B
[J]. PHARMACOLOGY, 1972, 7 (01) : 36 - &
[4] PHARMACOKINETICS OF MEZLOCILLIN IN HEALTHY VOLUNTEERS
BERGAN, T
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (06) : 801 - 806
[5] PHARMACOKINETICS AND BIOLOGICAL AVAILABILITY OF ERYTHROMYCIN
CHUN, AHC
SEITZ, JA
[J]. INFECTION, 1977, 5 : 14 - 22
[6] PHARMACOKINETICS OF ERYTHROMYCIN ON REPETITIVE DOSING
COLBURN, WA
DISANTO, AR
GIBALDI, M
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (10) : 592 - 600
[7] DIEM K, 1970, DOCUMENTA GEIGY SCI, P711
[8] Grove D.C., 1955, ASSAY METHODS ANTIBI
[9] INTESTINAL SECRETION OF ERYTHROMYCIN BASE
HOLLAND, DR
QUAY, JF
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (03) : 417 - 419
[10] JOHNSON JD, 1980, J LAB CLIN MED, V95, P429